Print Page

ADRs that result in revision of product information or suspension of marketing authorisation
 
Australia: Medicines containing GLP-1 and dual GIP/GLP-1 receptor agonists
 
 
 
Attachment:
  1. Australia: Medicines containing GLP-1 and dual GIP/GLP-1 receptor agonists  
Related Information:
Canada: Summary Safety Review: Glucagon-like Peptide 1 Receptor Agonists (GLP-1 ... Posted 2026-05-02
United Kingdom: GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pu... Posted 2025-02-01
New recommendations for GLP-1 receptor agonists to minimise risk of aspiration a... Posted 2024-07-15
European Union: New recommendations for GLP-1 receptor agonists to minimise risk... Posted 2024-07-13
 
back